- Home
- YALA vs SYRE Comparison
YALA vs SYRE Comparison
Compare YALA & SYRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- YALA
- SYRE
- Stock Information
- Founded
- YALA 2016
- SYRE 2013
- Country
- YALA United Arab Emirates
- SYRE United States
- Employees
- YALA N/A
- SYRE N/A
- Industry
- YALA Computer Software: Programming Data Processing
- SYRE Biotechnology: Pharmaceutical Preparations
- Sector
- YALA Technology
- SYRE Health Care
- Exchange
- YALA Nasdaq
- SYRE Nasdaq
- Market Cap
- YALA 1.1B
- SYRE 1.1B
- IPO Year
- YALA 2020
- SYRE 2016
- Fundamental
- Price
- YALA $7.66
- SYRE $14.84
- Analyst Decision
- YALA
- SYRE Buy
- Analyst Count
- YALA 0
- SYRE 5
- Target Price
- YALA N/A
- SYRE $55.00
- AVG Volume (30 Days)
- YALA 520.0K
- SYRE 438.2K
- Earning Date
- YALA 11-10-2025
- SYRE 11-06-2025
- Dividend Yield
- YALA N/A
- SYRE N/A
- EPS Growth
- YALA 14.19
- SYRE N/A
- EPS
- YALA 0.81
- SYRE N/A
- Revenue
- YALA $348,190,638.00
- SYRE N/A
- Revenue This Year
- YALA $3.51
- SYRE N/A
- Revenue Next Year
- YALA $12.39
- SYRE N/A
- P/E Ratio
- YALA $9.21
- SYRE N/A
- Revenue Growth
- YALA 6.79
- SYRE N/A
- 52 Week Low
- YALA $3.83
- SYRE $10.91
- 52 Week High
- YALA $9.29
- SYRE $40.26
- Technical
- Relative Strength Index (RSI)
- YALA 48.80
- SYRE 34.69
- Support Level
- YALA $7.35
- SYRE $15.80
- Resistance Level
- YALA $7.79
- SYRE $17.58
- Average True Range (ATR)
- YALA 0.20
- SYRE 0.75
- MACD
- YALA -0.02
- SYRE -0.20
- Stochastic Oscillator
- YALA 50.83
- SYRE 3.52
About YALA Yalla Group Limited each representing one
Yalla Group Ltd is a MENA-based online social networking and gaming company. It operates two flagship mobile applications, Yalla, a voice-centric group chat platform, and Yalla Ludo, a casual gaming application featuring online versions of board games popular in MENA, with in-game voice chat and localized majlis functions. The Group has one operating segment, which is the social networking and entertainment platform.
About SYRE Spyre Therapeutics Inc.
Spyre Therapeutics Inc is a biotechnology company that aims to create the next-generation of inflammatory bowel disease (IBD) products by combining antibody engineering, rational therapeutic combinations, and precision medicine approaches for patient selection. IBD is a chronic condition characterized by inflammation within the gastrointestinal tract, including two main disorders which are UC and CD. It has a single reportable segment, which is the development of biopharmaceutical products for the treatment of patients with IBD and other immune-mediated disease.